Amatica's 31 Marker & RNA Sequencing Tests for M.E. & LC with Nick Boyd-Gibbins & Jack Hadfield

Renegade Research Clinician's Roundtable with Nick and Jack, co-founders of Amatica Health discuss their 31 Marker test results in ME/CFS & Long COVID, their RNA sequencing test, and their mission as a whole, including how they plan to go about tackling solving ME/CFS & Long COVID.

0:00 Opening the Zoom Room
0:00:36 Welcome by Isabel
0:03:06 Nick Boyd-Gibbins begins
0:05:05 Nick’s story
0:07:44 Jack’s story
0:10:58 Amatica’s story
0:23:07 Next Year Rolling Out most extensive autoantibody array ever released
directly to patients. It has 21,000 human auto antibody targets!!!!
And finally we will also integrate COVID persistence data.
0:25:27 About Amatica Tests, staring with 31 Marker Test
0:29:39 Found 3 subgroups.
0:31:30 RNA Sequencing
0:41:52 The pipeline of testing in development
0:42:11 The COVID persistence test!
0:43:29 Roll out of Most in-depth auto antibody array ever been available to patients.
0:46:38 Our most interesting 31 Marker Results
0:55:12 Individual Patient Example in PEM and not
1:09:23 Findings for a subset that has tried LDN (for example)
1:15:08 Also found statistical significance for antihistamines.
1:16:25 Amatica’s clinical Strategy
1:21:43 Q&A

2:03:26 End
​
Amatica combines molecular testing, proprietary analytics, and large-scale data science to make clinical discoveries. They adapt precision medicine methods that have already shown success in oncology to transform how these overlooked diseases are understood and treated.
​
Each patient’s test provides wide biomarker profiling which is analyzed alongside a detailed clinical profile software platform covering symptoms, disease profile and treatment outcomes. They aim to define precise subgroups and identify which treatments are most or least likely to help each patient.
​
Clinical assessment of patients is central to data fidelity. Their future clinician dashboard will provide accessible findings, offering real-time insights, aggregated data, and live updates on ongoing research. Their goal is to equip clinicians with the knowledge needed to make more informed, personalized decisions.

You can find more about them at https://amaticahealth.com/for-clinici...